Inhald

Inhaled Iloprost in Pulmonary Hypertension Association with Diastolic Dysfunction (INHALD)

Inhald

Description: Inhaled Iloprost in Pulmonary Hypertension Association with Diastolic Dysfunction (INHALD)

Drug: Iloprost

Primary Investigator: Engel

Drug/Device Information
Inhaled Iloprost in Pulmonary Hypertension Association with Diastolic Dysfunction
This trial is a single center, 12-week prospective, non-randomized investigation
An initial test dose of 2.5 mcg, followed by a 5.0 mcg test dose, will be administered at screening visit
If tolerated, a 5 mcg dose will be prescribed for administration 6 to 8 times per day for 12 weeks
Investigator directed trial